Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 14 tags : Alliances save search
Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: 1.34%
H: 0.63%
C: 0.52%
diabetes bioscience collaboration
CytRx Highlights ImmunityBio's Completion of Enrollment in Phase 2 Study of Advanced Metastatic Pancreatic Cancer Treatment
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
IBRX | $5.265 7.23% 6.74% 4.6M
|
Manufacturing
|
| O: 0.99%
H: 8.76%
C: 4.24%
treatment phase 2 cancer pancreatic pancreas enroll
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug Application for Phase 1 Clinical Trial in Non-Hodgkin’s Lymphoma
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.99%
C: 0.9%
new drug fda fda acceptance phase 1 cancer drug license trial
Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.82%
H: 0.83%
C: 0.0%
test genomic cancer bioscience collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.